Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries

Shigellosis causes considerable public health burden, leading to excess deaths as well as acute and chronic consequences, particularly among children living in low-income and middle-income countries (LMICs). Several Shigella vaccine candidates are advancing in clinical trials and offer promise. Alth...

Descripción completa

Detalles Bibliográficos
Autores principales: Giersing, Birgitte K, Isbrucker, Richard, Kaslow, David C, Cavaleri, Marco, Baylor, Norman, Maiga, Diadié, Pavlinac, Patricia B, Riddle, Mark S, Kang, Gagandeep, MacLennan, Calman A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2023
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603611/
https://www.ncbi.nlm.nih.gov/pubmed/37858591
http://dx.doi.org/10.1016/S2214-109X(23)00421-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603611/
https://www.ncbi.nlm.nih.gov/pubmed/37858591
http://dx.doi.org/10.1016/S2214-109X(23)00421-7

Ejemplares similares